1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed) is sponsored by National Institute on Aging (NIA). Supports development of machine learning and AI tools for genomic translational research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-AG-24-019: Notice of Participation of the National Institute on Aging in RFA-HG-24-004, "ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)" Notice of Participation of the National Institute on Aging in RFA-HG-24-004, "ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)" May 10, 2024 - ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed).
See NOFO RFA-HG-24-004 . This Notice informs that, effective immediately, the National Institute on Aging (NIA) is participating in RFA-HG-24-004 , ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed). To document NIAs participation, the following sections of RFA-HG-24-004 were modified: Part 1.
Overview Information Components of Participating Organizations National Human Genome Research Institute ( NHGRI ) All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Office of Data Science Strategy ( ODSS ) Modified to Read (changes shown in bold italics ): National Human Genome Research Institute ( NHGRI ) National Institute on Aging ( NIA ) All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Office of Data Science Strategy ( ODSS ) Assistance Listing Number(s) Modified to Read (changes shown in bold italics ): Part 2. Full Text of Announcement Section I.
Funding Opportunity Description This section was modified to add : National Institute on Aging (NIA) NIA leads the federal government in conducting and supporting research on aging and the health and well-being of older people and is the lead within NIH for research on Alzheimers disease and related forms of dementia (AD/ADRD).
To fulfill its mission, NIA supports technologies which aim to increase the research community's understanding of the aging process, as well as diseases, conditions, and needs associated with growing older, in order to extend the healthy, active years of life.
NIA invites proposed MAGen Site applications that align with NIA's mission and that focus on pathogenic variants that are associated with diseases and conditions associated with growing older, including those associated with AD/ADRD. Section VII.
Agency Contacts This section was modified to add : Scientific/Research Contact(s) Division of Neuroscience (DN) National Institute on Aging (NIA) E-mail: [email protected] Financial/Grants Management Contact(s) National Institute on Aging (NIA) E-mail: [email protected] All other aspects of the NOFO remain the same.
Please direct all inquiries to: Division of Neuroscience (DN) National Institute on Aging (NIA) E-mail: [email protected] Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: Nonprofits, Universities, State/local governments, For-profit organizations. Confirm the full requirements in the official notice before applying.
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed) is funded by National Institute on Aging (NIA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article